ArticleBlood advances2020

Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses.

Pierre-Edouard Debureaux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.